Cyrus Harmon is of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 756,283 shares of OLMA, which is worth approximately $11.5 Million. The most recent transaction as insider was on Nov 29, 2021, when has been sold 400 shares (Common Stock) at a price of $24.76 per share, resulting in proceeds of $9,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 756K
8.47% 3M change
27.19% 12M change
Total Value Held $11.5 Million

Cyrus Harmon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2021
SELL
Open market or private sale
$9,904 $24.76 p/Share
400 Reduced 0.04%
1,051,146 Common Stock
Oct 19 2021
SELL
Open market or private sale
$336,360 $28.03 p/Share
12,000 Reduced 1.13%
1,051,546 Common Stock
Sep 20 2021
SELL
Open market or private sale
$315,600 $26.3 p/Share
12,000 Reduced 1.12%
1,063,546 Common Stock
Aug 19 2021
SELL
Open market or private sale
$299,640 $24.97 p/Share
12,000 Reduced 1.1%
1,075,546 Common Stock
Jul 20 2021
SELL
Open market or private sale
$105,672 $25.63 p/Share
4,123 Reduced 0.38%
1,087,546 Common Stock
Jul 19 2021
SELL
Open market or private sale
$195,586 $24.83 p/Share
7,877 Reduced 0.72%
1,091,669 Common Stock
Jun 18 2021
SELL
Open market or private sale
$305,760 $25.48 p/Share
12,000 Reduced 1.08%
1,099,546 Common Stock
Nov 23 2020
BUY
Conversion of derivative security
-
71,374 Added 6.03%
1,111,546 Common Stock
Jun 15 2020
BUY
Grant, award, or other acquisition
-
143,472 Added 12.12%
1,040,172 Common Stock
CH

Cyrus Harmon

San Francisco, CA

Track Institutional and Insider Activities on OLMA

Follow Olema Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA